ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients
出版年份 2021 全文链接
标题
ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients
作者
关键词
-
出版物
Journal of Innate Immunity
Volume -, Issue -, Pages 1-11
出版商
S. Karger AG
发表日期
2021-12-02
DOI
10.1159/000519090
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
- (2020) Serena Colafrancesco et al. AUTOIMMUNITY REVIEWS
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
- (2020) George Dimopoulos et al. Cell Host & Microbe
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Characterization of the Inflammatory Response to Severe COVID-19 Illness
- (2020) Oliver J McElvaney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases
- (2020) Kai Kappert et al. BIOMARKERS
- A minimal common outcome measure set for COVID-19 clinical research
- (2020) John C Marshall et al. LANCET INFECTIOUS DISEASES
- Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
- (2020) Raphaël Cauchois et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series
- (2020) Iris Navarro‐Millán et al. Arthritis & Rheumatology
- Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI
- (2020) Tariq U. Azam et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effects of Tocilizumab in COVID-19 patients: a cohort study
- (2020) Christine A. Vu et al. BMC INFECTIOUS DISEASES
- The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
- (2020) Mathieu Blot et al. Journal of Translational Medicine
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
- (2020) Giorgio Bozzi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started